Autonomous parvoviruses preferentially replicate in and kill in vitro ± transformed cells and reduce the incidence of spontaneous and implanted tumors in animals. Because of these natural oncotropic and oncolytic properties, parvoviruses deserve to be considered as potential antitumor vectors. Here, we assessed whether parvovirus H1 is able to kill human hepatoma cells by induction of apoptosis but spares primary human liver cells, and whether the former cells can efficiently be transduced by H1 virus ± based vectors. Cell death, infectivity, and transgene transduction were investigated in Hep3B, HepG2, and Huh7 cells and in primary human hepatocytes with natural and recombinant H1 virus. All hepatoma cells were susceptible to H1 virus ± induced cytolyis. Cell death correlated with H1 virus DNA replication, nonstructural protein expression, and with morphological features of apoptosis. H1 virus ± induced apoptosis was more pronounced in p53 -deleted Hep3B and p53 -mutated Huh7 cells than in HepG2 cells which express wild -type p53. In Hep3B cells, apoptosis was partially inhibited by DEVD -CHO, a caspase -3 inhibitor. In contrast, H1 virus ± infected primary hepatocytes were neither positive for nonstructural protein expression nor susceptible to H1 virus ± induced killing. Infection with a recombinant parvovirus vector carrying the luciferase gene under control of parvovirus promoter P38 led to higher transgene activities in hepatoma cells than in the hepatocytes. Taken together, H1 virus kills human hepatoma cells at low virus multiplicity but not primary hepatocytes. Thus, recombinant H1 viruses carrying antitumor transgenes may be considered as potential therapeutic options for the treatment of hepatocellular carcinomas. Cancer Gene Therapy ( 2001 ) 8, 158 ± 167
H uman hepatocellular carcinoma (HCC ) is one of the most common malignancies and causes, with increasing incidence, an estimated 1 million deaths per year worldwide.
1,2 Unfortunately, surgical resection or liver transplantation, which can be curative for HCC, is appropriate treatment modality for only a minority of selected patients. None of the established medical options, such as percutaneous ethanol injection, transcatheter arterial chemoembolization, or systemic chemotherapy, has significantly improved the prognosis of patients with unresectable HCC. 2, 3 These discouraging results have necessitated the search for new therapeutic strategies.
The development of gene transfer techniques for cancer therapy is a rapidly expanding field: for HCC, different recombinant viruses have been assessed to transfer ( a) suicide genes that convert inactive prodrugs into cytotoxic compounds; ( b) cytokine genes that enhance immunogenicity of tumors; or ( c) tumor-suppressor genes to block tumor cell proliferation. 4 ± 9 Several of the viral delivery systems are limited by pathogenic or immunogenic side effects. 10, 11 We have considered the possibility of using autonomous parvoviruses as alternative vectors for tumor cell ± targeted gene therapy, in particular because of their oncotropic and oncolytic activities. 12 Parvoviruses are a group of small, nonenveloped viruses replicating in the nucleus containing a linear single -stranded DNA molecule about 5 kb long and bracketed by nonidentical palindromic hairpin loops. 13 Autonomously growing parvoviruses of rodent origin, hereafter referred to as parvoviruses, are seldom pathogenic to their natural adult hosts. 14 The rat virus H1 infects humans without any apparent clinical consequences. 12, 15 The low genetic complexity of autonomous parvoviruses renders their replication tightly dependent on cellular S -phase ±associated factors. 13 The H1 virus has two overlapping transcription units. 13 Transcripts from the left -handed promoter ( P4 ) are translated into the nonstructural proteins NS1 and NS2. The right -hand P38 promoter directs the synthesis of the capsid proteins (VP ). NS1 is a multifunctional nuclear phosphoprotein involved both in viral DNA synthesis and up -regulation of the P38 promoter. 13 The NS1 protein is cytotoxic and contributes to the lytic growth of parvoviruses. 16, 17 Characteristic features of apoptosis were observed after cell infection with parvovirus H1 and the related human parvovirus B19. 18 ± 21 Interestingly, the parvoviruses minute virus of mice and H1 virus preferentially replicate in and kill oncogene -transformed and tumorderived cells in culture. 12, 22, 23 Moreover, minute virus of mice and H1 virus reduced the incidence of spontaneous and chemically induced tumors in laboratory animals. 12 Furthermore, H1 virus showed curative activity against human tumor cell implants in immunodeficient animals. 24, 25 Tumor cell sensitivity to parvovirus attack is attributed to the production of viruses to produce large amounts of viral DNA, cytotoxic viral NS proteins compared to normal parental cells. Moreover, transformed cells display a greater intrinsic responsiveness to NS1 -mediated toxicity. 17 The inactivation of the tumor-suppressor gene p53 in the host cells was correlated with a greater cellular susceptibility to H1 virus ± induced killing, suggesting that deregulation of the cell cycle at the S -phase boundary plays an important role in the ability of cells to sustain parvoviral infection. 26 So far, only a few studies have investigated the susceptibility of a series of human tumor cells deriving from the same tissue to H1 virus ± induced toxicity. 24, 27, 28 As parvovirus replication is not restricted to tumors in the natural hosts ( rodents ), studies are needed to identify human tumor cells susceptible to parvovirus replication from which the normal parental cells resist such infection, apoptotic cell killing, and parvovirus -based gene transduction. Susceptibility of normal human cells to parvovirus infection would be considered as a drawback for the use of parvovirus vectors as antitumor agents as it may cause damage to healthy tissue. Therefore, we determined whether H1 virus can infect and kill HHC -derived tumor cells, and whether this cytolytic effect can be attributed to the induction of apoptosis. With regard to the possible clinical use of these viruses, we also characterized the effect of H1 virus infection on primary human liver cells. Using two types of recombinant parvoviruses that both carry a reporter gene, we prospected the capacity of these H1 virus ± based vectors to efficiently transduce their transgene in liver tumor cell lines and in primary human hepatocytes.
MATERIALS AND METHODS

Tumor cells and primary human hepatocytes
Huh7 and Hep3B cells were derived from human HCCs, HepG2 cells from a human hepatoblastoma. 29 Huh7 and HepG2 were propagated in Dulbecco's modified Eagle's medium ( Life Technologies, Karlsruhe, Germany ) and Hep3B in Eagle's minimal essential medium ( Eurobio, Raunheim, Germany ) , all media supplemented with 10% fetal calf serum ( FCS ), 5 mmol / L glutamine, 100 g/mL penicillin, and 5 mol /L Hepes. 29 The simian virus 40 ± transformed newborn human kidney cell line (NB -E ) was propagated in minimal essential medium (Life Technologies ) with 5% fetal calf serum, 5 mmol / L glutamine, and 100 g /mL penicillin. 22 Exponentially growing cultures 30 Briefly, the resected piece of liver was perfused via a central vessel, first with Dulbecco's modified Eagle's medium, and then with William's medium E (WME ) containing 0.05% collagenase and 5 mmol /L calcium. Cell suspension was filtered through a gauze, washed four times with ice -cold WME containing 5% fetal calf serum, and seeded at a density of 1Â10 5 viable cells/cm 2 on collagen -coated culture dishes. Medium was changed 0.5 h after plating and every day thereafter. For cell maintenance, WME was used, supplemented with 0.066 mol /L insulin, 0.1 mol / L glucagon, 0.1 mol /L triiodothyronine, 5 mmol /L glutamine, 37 mol / L inosine, 10 g /mL gentamycin, 100 g/ mL penicillin, and 20 mmol /L Hepes. 30 Virus infection, production, and cytotoxicity H1 virus was propagated in NB -E cells and purified over cesium chloride gradients as described earlier. 22 Wildtype (wt ) H1 titration by plaque assay was performed according to published methods. 22 The multiplicity of infection ( MOI ) is given by the number of plaqueforming units (pfu ) inoculated per cell. For H1 virus infection, exponentially growing cultures of hepatoma and NB -E cells were infected for 1 hour at different MOIs. Cells were cultured for up to 8 days postinfection ( p.i. ) . As negative controls, inactivated wt H1 virus (UV irradiation with 258 nm, 170 J/ m 2 ; survival 10 À 7 ) was used in assays for infection, cytotoxicity, and viral DNA replication. Recombinant parvoviruses were titered by infected cell hybridization assays and expressed as replication units (RU ) per milliliter. 31 For wt H1 virus, pfu and RU values are similar.
Parvovirus -induced cytotoxicity
H1 virus ± infected cells were stained with crystal violet for 20 minutes, washed twice with phosphate -buffered saline ( PBS ), and air-dried. The growth inhibition (percentage of survival ) was defined as percentage reduction of photometric absorption measurements (550 nm ) of H1 -infected versus noninfected cell cultures by an enzyme -linked immunoassay reader. To reduce the growth effect of noninfected cells on the percentage of cell reduction, all photometric calculations at the day of experiment (output index ) were correlated with the input index on day 0 p.i. ( output /input ratio ). To investigate H1 virus ± induced cytotoxicity in primary human hepatocytes, 6Â10 4 liver cells were seeded on chamber slides for 24 hours, H1 virus ± infected (MOI= 5 pfu /cell ) , and cultured for 5 days p.i. After trypsination, cell numbers were counted using a hemocytometer. Activities of liver specific enzymes, aminoaspartate transferase, aminoalanine transferase, and lactate dehydrogenase were determined in supernatants of H1 -infected ( MOI =5 pfu/cell ) and noninfected primary liver cells according to the guidelines of the German Society of Clinical Chemistry. the cell cultures 6 hours before and 1 hour after H1 virus infection and cells were subjected to FACS analysis.
Morphological studies
Morphological studies were performed by chromatin staining [ 4 H ,6 -diamidino -2 -phenyl -indole (DAPI), Boehringer, Germany ] and phase -contrast microscopy in hepatoma cells and primary hepatocytes for up to 8 days p.i. For DAPI staining, cells were plated on coverslips, fixed in methanol for 10 minutes and followed by a 5-minute incubation in acetone. After DAPI staining, cells were washed twice with PBS and air-dried. 29 The cover slips were viewed under a fluorescence microscope (Zeiss, Jena, Germany ) .
Viral DNA amplification and protein analysis
For Southern blotting, cells were H1 virus ± infected at a MOI of 5 pfu /cell and were incubated for 0, 4, 30, and 60 hours. Low -molecular-weight DNA was selectively extracted using a modified Hirt procedure. 31 Briefly, virusinfected cells were suspended in lysis buffer [0.6% sodium dodecyl sulfate (SDS ), 10 mmol /L Tris ± HCl, 0.1 mmol / L EDTA ]. After DNA precipitation, the supernatant was treated with 100 g/mL RNase A and with 100 g/mL proteinase K. Hirt extracts were separated by agarose electrophoresis, transferred under high salt conditions to a Hybond -N + nylon filter ( Amersham Pharmacia Biotech, Freiburg, Germany ), and hybridized against a 1-kb± long 31 Membranes were washed under highly stringent conditions and autoradiographed.
For protein analysis, all cells were H1 virus ± infected at a MOI of 5. After washing with PBS, cells were lysed in RIPA buffer ( 10 mmol /L Tris ± HCl, 150 mmol /L NaCl, 1 mmol /L EDTA, 1% Nonidet P -40, 0.5% sodium deoxycholate, 5% SDS ) containing protease inhibitors. Protein concentrations were determined by Bio -Rad protein assay ( Bio -Rad, Munich, Germany ) . Fifty micrograms of total proteins was diluted into an equal volume, subjected to SDS polyacrylamide gel electrophoresis, and transferred onto a nitrocellulose membrane ( Amersham Pharmacia Biotech ). Nonspecific binding sites were blocked by incubating for 2 hours in PBS containing 10% low -fat milk powder and 0.2% Tween -20 ( Sigma, Deisenhofen, Germany ). Blot incubation was performed with a rabbit polyclonal antibody SP8 directed against carboxy -terminal peptides of NS1. 32 Blots were further incubated with an antirabbit peroxidase -conjugated antibody and processed with enhanced chemoluminescence ( Amersham Pharmacia Biotech ).
Recombinant viruses and luciferase expression
Two recombinant parvoviruses were used. In one ( hH1Á1600luc) , the VP -encoding genes were replaced by the gene coding for the firefly luciferase. The construction and production of this recombinant H1 virus have recently been described. 31 The second recombinant virus ( P4luc ) carries the luciferase -encoding reporter gene whose expression is controlled by the viral P4 promoter as described by Maxwell et al. 33 Recombinant viruses were produced in 293T cells by providing NS or both, NS and VP proteins in trans. 31, 33 In recombinant virus stocks, the wt H1 contamination was less than 0.01%. Wildbad, Germany ) and expressed as relative light units ( RLU ) .
RESULTS
H1 virus cytotoxicity, induction of apoptosis, and replication in human hepatoma cells
The growth of H1 virus ±inoculated Hep3B, Huh7, HepG2, and NB -E control cells was monitored by viability staining for up to 8 days p.i. ( Fig 1 ) . A significant MOI -dependent reduction of cell survival was observed for all hepatoma cell cultures compared with their noninfected controls. Although differences in sensitivity were observed between hepatoma cells during the first days p.i., after 8 days, the viability of infected cells (MOI= 20 pfu /cell ) was decreased to less than 10% of the noninfected controls. HepG2 cells were less susceptible to H1 virus ± induced killing than Hep3B and Huh7 cells at all MOIs tested. NB -E cells used for continuous H1 virus production showed the greatest sensitivity. UV irradiation of H1 virus completely abolished the cytotoxic effects in all cell lines ( data not shown) . To analyze the mode of cell death, morphologic changes in H1 virus ±infected hepatoma cells were first investigated by DAPI staining ( Fig 2 ) . Starting on day 2 p.i. to day 6 p.i., infected cell cultures displayed an increased proportion of cells with intense chromatin condensation, fragmentation of the nuclei, and formation of apoptotic bodies. Because flow cytometry remains the methodology of choice to study the apoptotic cascade in relation to cell type, trigger, and time, 34 FACScan with Annexin V and propidium iodide staining of H1 -infected hepatoma cells was performed to quantify the proportion of apoptotic versus necrotic cells. In concordance with the viability assay, a decrease in the number of living hepatoma cells was detected over the period of day 1 ± 5 p.i. At days 3 and 6, H1 virus ±infected p53-deleted Hep3B and p53-mutated Huh7 cells presented over 50% apoptotic cells using FACScan analysis (Fig 3, A and B ) . HepG2 cells, which express wt p53, were less susceptible to H1 virus ± induced apoptosis and even showed an increase of necrotic cells after H1 virus incubation ( Fig 3, C and D ) . Furthermore, the caspase -3 inhibitor DEVD -CHO reduced H1 virus ± induced apoptosis in p53 -deficient Hep3B cells ( Fig 3D ) . However, the H1 virus ±induced cell killing in Huh7 and HepG2 cells was only slightly inhibitable by DEVD -CHO ( data not shown ).
In order to evaluate the process of H1 virus replication in more detail, parvoviral DNA amplification and expression of the cytotoxic NS1 protein were analyzed in H1 -infected hepatoma cells. Internalized H1 virus is transferred to the nucleus, uncoated, and the input single -stranded DNA is converted into a double -stranded monomeric replicative form (mRF ) . The mRF DNA is amplified to multimeric forms, e.g., dimer-length molecules (dRF ) , which serve as templates for the synthesis of progeny ssDNA. 13 As shown in Figure 4 , these viral DNA replicative intermediates were present in all infected hepatoma cells, although in lower amounts than in infected NB -E cells. A steady increase of amplified DNA replicative intermediates was observed during the first 2± 3 days p.i. in all infected cells. In HepG2 cells, lower levels of viral DNA were detected as compared with Huh7 and Hep3B cells (Fig 4) . Furthermore, the production of infectious H1 virions was quantified by plaque assays on NB -E indicator cells ( Fig 5 ) . Despite the fact that the three hepatoma cell lines showed a delayed response to parvoviral -induced toxicity compared with the NB -E cells, the levels of infective virus reached nearly equivalent titers as those obtained with the latter cells. On the contrary, UV inactivation of the H1 virus inoculum blocked H1 DNA replication and virus production in all experiments (data not shown) .
With time, increasing amounts of NS1 were detected in the virus -infected hepatoma cells as detected by immunoblot analysis (Fig 6) . The amounts of NS1 protein accumulated in Hep3B and Huh7 cells were higher than in HepG2 cells, in accordance with the respective levels of viral DNA intermediates detected in the cells (Fig 4 ) . The highest NS1 levels were obtained in the NB -E cells, known to be very susceptible to H1 virus ±induced cytotoxicity. 22 Primary hepatocytes are not susceptible to H1 virus ± induced cell killing
In parallel with the experiments described above, parvoviral H1 infection was investigated in freshly isolated primary human hepatocytes. The hepatocytes were virus -infected ( MOI =5 pfu /cell ) and the number of viable cells was monitored over time. The number of living cells from H1 virus ± infected and from mock -infected cultures did not differ significantly at all times p.i. analyzed, suggesting that H1 virus did not kill primary hepatocytes to significant extents ( Fig 7A ) . Because the S-phase traverse is necessary for parvoviruses to replicate and exert their toxic activity, 13 it should be noted that the primary hepatocytes are able to go through the S -phase but unable to divide under the culture conditions used. 35, 36 To confirm the apparent lack of H1 -induced cytotoxicity to primary liver cells, the release of aminoaspartate transferase, aminoalanine transferase, and lactate dehydrogenase was determined in tissue culture supernatants. No differences between H1 virus ± infected and control liver cells were observed ( Fig 7B ) . Phase contrast microscopy and DAPI staining of infected and noninfected primary hepatocytes did not reveal any morphological change within 5 days p.i., strongly suggesting that normal liver cells are resistant to H1 virus ± induced killing under the experimental conditions used ( Fig 7C ) . In addition, parvoviral DNA replication and expression of the cytotoxic NS1 protein were analyzed over time. In contrast to the three hepatoma cells analyzed, neither H1 virus DNA replicative intermediates nor production of parvoviral nonstructural proteins could be detected in the H1 virus ±infected untransformed hepatocytes ( data not shown) . Thus, these data extend the oncotropic behavior of H1 virus to human hepatoma cells.
Efficient gene transduction by means of recombinant parvoviruses in hepatoma cells but not in primary hepatocytes
The data described above suggest that H1 virus may be harmless to normal hepatocytes in vivo. Thus, H1 might be useful as vector for the treatment of HHCs as it replicates in and kills those cells. Therefore, H1 virus ±mediated gene transfer was assessed using two different H1 virus ± derived recombinant parvoviruses, both carrying the luciferaseencoding reporter gene (luc ), either under the control of the parvoviral promoter P4 (P4luc ) or under the control of the NS1 -transactivated second virus promoter p38 ( hH1Á1600luc ). The two recombinant viruses are schematically depicted in Figure 8A . The hH1Á1600luc vector carries the parvoviral gene encoding the viral NS proteins, thus conferring replicative potential to the recombinant virus in susceptible cells.
31 H1 virus ± mediated transduction of the luc gene was monitored by determining the luciferase activity in the infected cell extracts (Fig 8, B and C ) . Despite the fact that the multiplicities of virus infection were very low (1Â10 À 2 RU /cell ) , high luciferase activities were measured in the hepatoma cells with both types of recombinant H1 viruses. The genome replication ±competent hH1Á1600luc virus showed significantly higher luciferase activity than the NS -deficient P4luc virus because of its capacity for amplifying the viral genome and ability of NS1 to transactivate the P38 promoter. After a peak on day 2 p.i. ( Fig 8B ) , luciferase activity decreased, but remained high up to 4 days p.i. ( Fig 8C ) . In accordance with their capacity to sustain higher viral DNA replication levels and their greater susceptibility to virus -induced cytotoxicity during the first days p.i., Hep3B and Huh7 cells displayed higher luciferase activities than HepG2 cells. Hence, the transduction efficiency correlated with the cellular susceptibility to H1 virus ± induced killing. In contrast, luciferase activity transferred by recombinant hH1Á1600luc-infected primary human hepatocytes 2 and 4 days p.i. was significantly less efficient than the transgene transduction achieved in the hepatoma cells (Fig 8, B and C ) .
DISCUSSION
In this study, we characterized three human hepatoma cell lines and primary hepatocytes for their susceptibility to H1 virus infection and cell killing, and we evaluated their amenability to gene transfer after recombinant parvovirus infection. In most human and rodent cell systems studied so far, susceptibility to H1 virus ±induced cell killing correlated with the capacity of the host cells to sustain parvoviral DNA amplification, NS1 protein expression, or both. 12, 15, 17, 22, 23 Similarly, the H1 virus ± induced killing of human hepatoma cells was dependent on the MOI, and correlated with H1 DNA replication and NS1 protein expression levels. H1 virus was also able to induce programmed cell death in human hepatoma cells, as it was shown for other cell types and by other hepatotropic viruses. 18, 19, 35, 37 In several cases, tumor cells were more sensitive to H1 -induced toxicity than their nontransformed parental cells. 12, 22, 23 Thus, human hepatoma cells constitute an additional system in which a selective killing by H1 virus could be achieved in the transformed, but not in the primary, hepatocytes. The primary human liver cells were freshly isolated from different human livers. The resistance of these hepatocytes to H1 virus ± induced cell killing cannot simply be attributed to their nondividing status because they can traverse the S -phase under the culture conditions used, 30, 36, 38 which is a prerequisite for H1 to replicate and to become cytocidal. 13 It may be argued that long -time culturing of the tumor-derived cells may have caused a drift to a greater permissivity of those tumor cells to parvovirus infection. However, freshly isolated breast and gastric tumor cells from different patients could be better infected by H1 virus than the corresponding normal cells, 27, 28 suggesting that these tumor cells were susceptible to H1 virus infection before their establishment as permanent lines. Similarly, simian virus 40 ±transformed human fibroblasts became sensitive to H1 infection before or after their immortalization. 22 Furthermore, an EBV-transformed lymphocyte cell line displayed H1 virus DNA replication, whereas different nontransformed, long -cultured lymphocyte cell strains did not ( data not shown ).
Despite the fact that we did not report on direct molecular events, our present study revealed further hints to the cellular process underlying the parvovirus -induced tumor cell killing. S -phase factors such as p53, cyclin A, and RPA are involved in the regulation of parvovirus DNA replication. 26, 39 In this study, we found a clear-cut correlation between H1 virus replication ability, H1 -induced apoptotic cell death, and the inactivation of wt p53, thus confirming the correlation between p53 tumor-suppressor gene expression and cellular resistance to H1 -induced killing. 26 Indeed, rare H1 virus ± resistant variant clones named KS cells were isolated from the H1 virus ± susceptible human p53 -negative erythroleukemic cell line K562. KS cells appeared to differ from the parental cells by their expression of wt p53 and by a reduced oncogenic potential in immunocompromised mice. Similarly, rat embryo fibroblasts, which overexpressed mutant p53 protein, were more sensitive to H1 virus infection than the parental cells. 26 In our experiments, hepatoma cells such as the p53 -impaired Hep3B and Huh7 cells were more susceptible to H1 DNA replication and H1 virus ± induced apoptosis than the wt p53 expressing HepG2 cells. Moreover, apoptosis of Hep3B cells was reduced by the caspase-3 inhibitor DECD -CHO, suggesting a H1 virus ± induced caspase -3 ± dependent programmed cell death.
It is the aim of tumor-targeted gene therapy approaches to selectively kill malignant cells. 10, 11 Our data strongly suggest that recombinant parvoviruses may constitute appropriate antitumor agents for the treatment of HCCs. Because both recombinant parvoviruses tested in this study did not carry capsid genes, the H1 -mediated transgene transduction was a one-hit phenomenon excluding secondary infections. A replication-competent H1 virus vector of the hH1Á1600luc type may be the recombinant parvovirus of choice to achieve high expression levels of both the toxic viral NS1 protein and of an additional suicide or cytokine gene in HCCs. 5 ± 9 This approach seems feasible as it was recently shown that H1 virus ±based vectors of the hH1Á1600luc type, which harbor cytokine genes or the HSV-tk gene under control of the P38 promoter, can be prepared. 40 ± 42 The cytokine-transducing parvoviruses were able to produce very high cytokine levels in HeLa cells at low input multiplicities and IL -2 virus was able to abrogate tumor formation in nude mice. 42 In summary, we have shown that at low virus multiplicities, H1 virus is particularly cytotoxic for human hepatoma cells and that recombinant H1 viruses have a high capacity to transduce transgenes in these cells. Because no detrimental effect of H1 virus incubation could be observed in primary human liver cells in vitro, this virus is expected to be even less harmful for primary hepatocytes in vivo because these cells do not replicate in the liver under normal circumstances. Most importantly, our results strongly suggest that p53-impaired liver tumors, which have a poor prognosis, may be particularly suitable to parvovirus therapy. 43 ± 45 Though the p53 deficiency in tumors may induce resistance to chemotherapeutic agents, this will not affect the liver tumor cell susceptibility to parvoviral oncolytic infections. 46 Hence, the therapeutic potential of H1 virus ±based recombinant vectors carrying suicide genes or cytokines, which may also overcome other tumor resistance mechanisms against autocrine and paracrine apoptotic triggers developed in these tumor entities, should be assessed in HCCs. 46, 47 
